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Abstract 
Ever since man domesticated the first wild animals several thousand years ago, many 
species have been living in close relationship with humans, being objects for our 
requests and wishes about any kind of phenotypic traits. As a result, we have by 
selective breeding created a fascinating spectrum of phenotypes within most species 
we have domesticated. The broad aim of this thesis has been to investigate the 
molecular mechanisms causing different colour and pattern phenotypes in domestic 
animals. In more detail, the mutation causing Greying with age and melanoma in 
horses and the mutations leading to the Sex-linked barring feather pattern in the 
domestic chicken have been studied. 
Grey horses are born any colour, but gradually loose their hair pigmentation and 
usually become white by the age of 6-8 years. The pigmentation loss only affects 
the  hair,  and  the  skin  stays  dark  throughout  life.  Melanomas  and  vitiligo-like 
depigmentation frequently occur among Grey horses, and it is claimed that 70-80% 
of Grey horses older than 15 years have melanocytic lesions. The Sex-linked barring 
pattern  in  chickens  is  characterized  by b l a c k  a n d  w h i t e  s t r i p e s  o n  t h e  f e a t h e r s .  
Similar barring patterns are found among many bird species, such as the peregrine 
falcon and the zebra finch. The mutation causing Sex-linked barring has previously 
been  mapped  to  the  q  arm  of  chromosome  Z,  which e x p l a i n s  w h y  t h e  
homogametic (ZZ) sex in chickens, males, develop a broader barring pattern. 
  In  this  thesis,  the  mutations  causing  both  traits  are  identified,  and  their 
functional properties are investigated. The mutation causing Greying with age and 
melanoma in horses was identified as a 4.6 kb intronic duplication in the gene 
STX17, not previously linked either to pigmentation or melanoma. Moreover, it 
could  be  shown  that  the  mutation  in  STX17 h a s  a n  e l e v a t e d  c o p y  n u m b e r  i n  
melanoma  DNA,  and  that  it  contains  a  strong  melanocyte  specific  activating 
regulatory element residing a MITF binding site. This finding sheds further light on 
the intriguing molecular processes of melanoma development. The mutations linked 
to  Sex-linked  barring c o u l d  b e  m a p p e d  t o  t h e   CDKN2A/B t u m o u r  s u p p r e s s o r  
locus, a genetic region commonly associated with familiar forms of melanoma and 
also implied in the molecular mechanisms of pigmentation regulation.  
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We inhabit ourselves without valuing ourselves, unable to see that here, now, this 
very moment is sacred; but once it’s gone – its value is incontestable. 
Joyce Carol Oates  
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Aims of this Thesis 
 
The  broad  aim  of  this t h e s i s  h a s  b e e n  t o  i n v e s t i g a t e  t h e  m o l e c u l a r  
mechanisms  causing  different  colour  and  pattern  phenotypes  in  domestic 
animals. The specific aims have been to: 
 
 
I  Characterize and functionally dissect the mutation causing Greying with 
age and melanoma in horses. (Papers I, III and IV) 
 
 
II  Elucidate the functional properties of the mutations in the CDKN2A/B 
locus causing the black and white Sex-linked barring feather pattern in 
the domestic chicken. (Paper II) 
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Introduction 
Why study pigmentation in animals? 
Since man domesticated the first wild animals several thousand years ago, 
predominantly  in  the  fertile  crescent o f  t h e  M i d d l e  E a s t ,  a  c o n t i n u o u s  
selection  for  many  different  traits  has  been  performed.  Through 
domestication,  many  animals  have  been  living  in  close  relationship  with 
humans, becoming objects to mould phenotypically; from body size to coat 
colour or length of the nose or tail. By selective breeding, we have created a 
spectrum of phenotypes within most species we have domesticated. As an 
example, there are dogs varying in size from as tiny as a rat to as big as a 
small pony, and their fur colour and pattern can range between completely 
black,  golden, w h i t e ,  s p o t t e d  o r  p a t c h e d .  T h e  f a c t  t h a t  w e  s e e  a  l a r g e  
phenotypic variation indicates that the molecular pathways resulting in every 
trait  must  show  biological d i f f e r e n c e s  f r o m  e a c h  o t h e r .  By  studying  the 
molecular mechanisms behind phenotypic variants in animals, we can reach 
interesting conclusions about the basic molecular processes regulating size, 
colour and pattern. Additionally, mammals, including humans, have many 
genes  in  common,  and  consequently,  many  signalling  pathways  are 
conserved between different species and are operated in similar manners. By 
studying  the  phenotypic  variation  in  animals,  it  is  therefore  possible  to 
pinpoint molecular processes and key genes that play a similar role also in 
humans. 
   16 
Melanocyte biology and the molecular basics of pigmentation 
Pigment cell development 
The cell type responsible for producing pigment, the melanocyte, is derived 
from  the  neural  crest  and  migrates  into  various  body  tissues  during 
embryonic development (Mayer, 1973). Recent findings also indicate that 
many skin melanocytes may derive from Schwann cell precursors (SCPs), 
which  reside a l o n g  n e r v e  c e l l s  t h r o u g h o u t  t h e  b o d y  (Adameyko  et  al., 
2009).  The  neural  crest  origin  is  mirrored  in  the  dendritic  shape  of  the 
melanocyte, which highly resembles the stretched structure of a neuron.  
During  embryogenesis  in  mice,  melanoblasts  differentiate  from 
pluripotent neural-crest cells at about embryogenic day (E) 8.5, migrating 
along the dorsolateral pathway and eventually proceeding ventrally through 
the  dermis  (Lin  and  Fisher,  2007).  From  the  dermis,  the  melanocytes 
continue their migration to the epidermis at day E14.5, and at this point 
they also populate the developing hair follicles (Lin and Fisher, 2007). 
Many  different  signaling  pathways  and  transcription  factors  tightly 
regulate melanocyte development and migration. Some of the most crucial 
genes for melanocyte development include PAX3 (paired-box 3), SOX10 
(sex-determining  region  Y  (SRY)-box  10),  MITF ( Microphthalmia-
associated  transcription  factor),  EDN3 ( e n d o t h e l i n  3 )  a n d  EDNRB 
(endothelin receptor B). Mutations in the key genes governing melanocyte 
development are manifested as hypopigmentation; a consequence of the lack 
of  melanocytes, r a t h e r  t h a n  the  lack  of  pigment  in  viable  melanocytes, 
which is the case in albinism (Lin and Fisher, 2007). 
Inside the melanocyte, the pigment is produced in a specific organelle, 
the melanosome. There are two main types of melanin molecules produced 
in  the  mature  melanocyte:  the  red/yellow  pheomelanin  and  the 
brown/black eumelanin. The two different types of melanin differ in several 
other aspects in addition to their colour, ranging from shape and size to the 
packaging of their granules (Slominski et al., 2004). 
 
 
Melanocytes in different tissues 
We may only think of the melanocyte as a “one-purpose” cell type, being 
present in our skin and hair follicles where it gives the skin and hair colour. 
However, melanocytes and melanin can be found in many different parts of 
the body, where they pursue a wide variety of different functions (Figure 1). 
In addition to the skin and hair follicles, melanocytes reside in the heart,   17 
where  they  play  an  anti-inflammatory  role  and  protect  the  tissue  against 
reactive oxygen species (ROS), in the inner ear and cochlea, where they 
affect  balance  and  hearing,  in  the  adipose  tissue, w h e r e  t h e y  p r o m o t e  
cellular  survival  by  reducing  ROS a n d  in  the  eye, w h e r e  they p r o t e c t  
against  UV-radiation  (Plonka  et  al.,  2009).  In  the  rare  lung  disease 
lymphangioleiomyomatosis, the hyperproliferating smooth muscle cells have 
been shown to contain premelanosomes, and to express the melanocyte-
specific  proteins  PMEL17,  TYRP1 a n d  T YRP2  (Klarquist  et  al.,  2009). 
One  interpretaion  of  this  phenomenon  could  be  that  these  cells  revert 
towards  their  developmental  origins  and  express  the m e l a n o c y t e -specific 
markers (Klarquist et al., 2009, Plonka et al., 2009). 
 
Figure  1.  Different  locations  of  melanocytes a n d / o r  m e l a n i n  i n  t h e  b o d y .  
Illustration by Anders Sundström, modified from Plonka et al., 2009.   18 
 
In  the  brain,  melanocytes  reside i n  t h e  l e p t o m e n i n g e s ,  a  m e m b r a n e  
sourrounding the brain and spinal cord, whilst a specific melanin molecule, 
called neuromelanin, exists in the dopaminergic neurons of the substantia 
nigra  (Nordlund  et  al.,  2006).  Neuromelanin  consists o f  a e u m e lanin 
covered pheomelanin core and is thought to be an auto-oxidative product 
of dopamine, generated by tyrosine hydroxylase synthezised in the neurons 
(Nordlund  et  al.,  2006).  Neuromelanin a c c u m u l a t e s  w i th  age,  and  the 
function  could  be t o  r e m o v e  R O S  a n d  m e t a l s  t h a t  a r e  h i g h l y  t o x i c  t o  
neurons (Zecca et al., 2002). Neuromelanin has been detected in several 
mammals in addition to humans, namely gorillas, gibbons, baboons, horses 
and sheep (Marsden, 1961). In Parkinson’s disease, the melanized neurons of 
the  substantia  nigra  are  more  vulnerable  to  degeneration  than  the  non-
melanized  ones,  and  the  loss  of  dopaminergic  neurons  containing 
neuromelanin is highly associated with the disease (Zecca et al., 2002).  
 
 
Regulation of melanogenesis 
To date, more than 100 loci have been shown to be involved in mouse 
pigmentation (Bennett and Lamoreux, 2003). The seven-transmembrane G-
protein-coupled  melanocortin  1  receptor  (MC1R)  is  one  of t h e  m a j o r  
determinants of pigmentary phenotypes. The extension locus (Mc1r
e/e), with 
mutants showing a light red coat colour and wild type individuals being 
black, was first identified in mice (Robbins et al., 1993). Since then, mutant 
alleles in homologs have been identified in many mammals, spanning from 
the extinct mammoths (Rompler et al., 2006) to extant living dogs (Everts 
et  al.,  2000,  Newton  et  al.,  2000),  horses  (Marklund  et  al.,  1996) a n d  
humans (reviewed in Sturm, 2002).  
The  production  of  pigment  starts  with  external  signals  acting  on  the 
melanocyte, and MC1R located in the membrane of the melanocytes serves 
as  the  main  mediator  of  these  signals ( F i g u r e  2 ) .  MC1R  has  two  major 
agonists; the melanocortin peptide α-melanocortin stimulating hormone (α-
MSH) that is cleaved from the pro-opiomelanocortin precursor (POMC) 
and the adrenocorticotropic hormone (ACTH), which originates from the 
same precursor. Agouti signalling protein (ASIP) functions as an antagonist 
to MC1R (Furumura et al., 1996).  
 When α-MSH or ACTH interacts with MC1R, the intracellular levels 
of  cyclic  AMP  (cAMP)  are  elevated,  and  this  results  in  an  increase  in 
tyrosine expression and eumelanin production (Barsh et al., 2000, D'Orazio   19 
et  al.,  2006).  Tyrosinase  (TYR)  is n eeded  to  catalyze  the  oxidation  of 
tyrosine,  producing d o p a q u i n o n e ,  t h e  p r e c u r s o r  o f  b o t h  e u m e l a n i n  a n d  
pheomelanin.  High  levels  of  cAMP  also  increases t h e  e x p r e s s i o n  o f  t h e  
tyrosinase-related enzymes TYRP1 and TYRP2, which catalyze steps in the 
oxidative pathway leading from the precursor dopaquinone to eumelanin. 
ASIP antagonizes the binding of α-MSH to MC1R, resulting in a shift from 
eumelanin to pheomelanin production, as the intracellular levels of cAMP 
are lowered (Barsh, 1996). 
 
 
Figure 2. Regulation of melanogenesis in the melanocyte. Illustation by Elisabeth 
Sundström, modified from Barsh, 1996. 
 
 
Melanogenesis in skin and hair  
Both  hair  and  skin  contain  melanocytes  that  provide  the  tissues  with 
pigment.  But  the  presence  of  one  cell  type  in  different  tissues  does  not 
automatically suggest equal regulation of the cell populations, not even if 
they are as closely located as hair and skin. 
Most of the melanocytes in the skin reside in the basal epidermis where 
the pigment is transferred to neighbouring keratinocytes by melanosomes. 
Melanocytes can also be present in the dermis, but to what extent varies   20 
between mammalian species, between glabrous and non-glabrous skin and 
also  between  human  ethnical  groups  (Nordlund  et  al.,  2006).  The 
melanocytes in the hair follicle are distinct from those in the skin, and are 
derived from a pool of pigment stem cells in the hair bulb (Figure 3).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The epidermis, dermis and hair follicle. Mature melanocytes reside in the 
epidermis of the skin, occasionally also in the dermis, and in the hair bulb. Pigment 
stem  cells  mature  from  the  bulge  and  migrate  towards  the  bulb  where  they 
eventually enter the hair. Illustration by Anders Sundström, modified from Lin and 
Fisher, 2007. 
 
Several studies have in the last decade indicated an independent regulation 
of skin and hair melanocytes (Fitch et al., 2003, Rosengren Pielberg et al., 
2008, Van Raamsdonk et al., 2009). This was not entirely surprising, since 
the melanocyte populations are distinctly separated between hair and skin. 
Fitch and colleagues (2003) showed by the characterization of the ten mouse 
dark skin (Dsk) mutants that epidermal and dermal melanocyte populations 
could be regulated independently by a distinct set of genetic pathways (Fitch 
et al., 2003). This work was expanded by Van Raamsdonk and colleagues 
(2009),  and  the  closer i n v e s t i g a t i o n  s h o w e d  t h a t  t h r e e  s p e c i f i c  m o u s e  
mutations  in  two  different  G-protein-coupled  signalling  pathways,  the 
endothelin signalling pathway and the MC1R signalling pathway, affect hair 
and skin colour differently, and these mutations also have different outcomes 
in  dermis  versus  epidermis.  The  two  mutations  affecting  the  endothelin 
signalling  pathway  are  found  in  two  closely  related  α-subunits  of  the   21 
EDNRB receptor in melanocytes. These mutations darken hair and skin 
colour through different mechanisms: in the dermis, darkening is caused by 
an increased number of melanocytes, while in the hair, darkening is caused 
by  an  increase  in  pigment  production,  independent  of  the  number  of 
pigment cells. In turn, the Mc1r
e mutation does not couple the synthesis of 
eumelanin with pheomelanin in the epidermis as it does in hair follicles (i.e. 
when MC1R is blocked pheomelanin is produced, and when MC1R is 
active, eumelanin is produced), since eumelanin concentration is reduced in 
the tail epidermis, but pheomelanin is not increased (Van Raamsdonk et al., 
2009). These findings would indicate that the production of pheomelanin in 
the epidermis is not regulated by MC1R or Agouti. 
 
 
Melanoma 
It may seem contradictory that the melanocytes, while playing an important 
role  in  protecting  the  skin  from  harmful  UV-radiation,  are  also  the 
precursors for one of the most common types of cancer today: melanoma. 
Out of 50000 diagnosed cancer cases in Sweden, 2000 concern malignant 
melanoma (Edqvist, 2008). The incidence of the disease is steadily rising in 
the western parts of the world, and during the last 20 years the number of 
cases has doubled (Gray-Schopfer et al., 2007). If diagnosed early, melanoma 
can be surgically removed, but in the later stages where metastases have 
occurred,  the  prognosis  is  very  poor  and  the  median  survival  time i s  
estimated  to  only  six m o n t h s  (Cummins  et  al.,  2006).  The  fact  that 
melanoma  has  a  continuously  increasing  incidence,  underlines  the 
importance  of  investigating  the  basic  molecular  mechanisms  regulating 
pigment production and pigment cell proliferation and differentiation.  
 
 
Melanoma in animals 
Melanoma is not a malignancy restricted only to humans, it occurs naturally 
in several other species like horses (Lerner and Cage, 1973), cows (Miller et 
al., 1995), sheep (Smith et al., 2002), goats (Parsons et al., 1990, Hamor et 
al.,  1999),  swine  (Millikan  et  al.,  1973,  Oxenhandler  et  al.,  1979),  dogs 
(Cotchin,  1955,  Conroy,  1967),  cats  (Luna  et  al.,  2000),  opossums 
(Robinson  et  al.,  2000) a n d  b i r d s  (Saunders  and  Saunders,  1991).  Many 
domestic animals used predominantly for meat production, e.g. cows, sheep   22 
and swine, are slaughtered at an early age before they develop melanocytic 
tumours, whilst horses, cats and dogs usually have longer life spans and live 
long  enough  to  develop  melanomas.  Some  animals  are  also  used  as 
laboratory  models  to  study  the  molecular  mechanisms  of  melanoma 
development, e.g. zebrafish (Ceol et al., 2008), rat and mouse, but in these 
species the melanoma is induced and not naturally occurring. While the 
predominating cause of melanoma in humans is mutations caused by UV-
radiation,  most  melanomas  in  animals  seem  to  have  a  strong  genetic 
background.  The  alpaca  goat  and  the  opossum  could  be  two  exceptions 
where  UV-induced  melanoma  has  been  found  (Parsons  et  al.,  1990, 
Robinson  et  al.,  2000).  The  genetic  predisposition  to  melanoma  among 
certain animals makes them a valuable resource for identifying genes and 
mutations involved in the development and progression of melanoma. 
 
 
Horse melanoma 
Melanoma in horses commonly occurs among the so called Grey horses, 
which are born coloured, but become white by the age of 6-8 years. This 
process could be compared to the greying of human hair. The pigmentation 
loss only affects the hair, while the skin stays dark throughout life, indicating 
different cellular fates for the melanocytes in the hair follicle versus the skin. 
The Grey horse melanomas occur in many different breeds, usually in the 
later stages of life. It is generally claimed that 70-80% of Grey horses older 
than 15 years have melanomas (Sutton and Coleman, 1997, Fleury et al., 
2000), and that the lesions start to develop early, by the age of 5-6 years 
(Lerner and Cage, 1973). The primary tumours arise in the dermis of the 
glabrous skin and are usually benign. Metastases, or lesions in different parts 
of the body like in skeletal muscle, heart, abdominal fat and lymph nodes, 
do occur (Figure 4), but as indicated by Sutton and Coleman (1997), the 
presence  of  tumours  at  these  sites  gives  the  impression  of  multicentric 
origins rather than metastases from a solitary primary tumour. The authors 
also  noted  that t h e r e  i s  s o m e  c o r r e l a t i o n  b e t w e e n  t h e  p a t t e r n  o f  l e s i o n  
distribution and the likely paths of neural crest cells as they migrate towards 
the skin during embryonic development. 
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Figure 4. An internal tumour from a horse 
euthanized due to melanomas. The tumour is 
located in the shoulder cartilage and spans 18 
cm. Photo by Monica Seltenhammer. 
 
 
 
 
 
The tumours appear as black pigmented, hemispherical-shaped, well isolated 
nodules, and they are most frequently found in regions lacking hair, like 
underneath the tail, around the anus, perineum or genitalia, and occasionally 
also in the lips and the eyelids (Fleury et al., 2000). The tumours can grow 
big as an apple in size, and when cut into, the highly melanized content 
drips like black ink.  
Grey  horses  with  melanomas  also  develop  vitiligo-like  skin 
depigmentation, commonly seen on the muzzle and under the tail (Lerner 
and Cage, 1973). A possible cause for the depigmentation could be an auto-
immune reaction against all melanocytes due to the tumour development. 
Melanocytic  lesions  also  occur  in  non-Grey  horses,  but  are  very 
uncommon, and seldom show the same aggressiveness and growth ability as 
Grey horse melanomas. As shown by Rosengren Pielberg et al. (2008), the 
incidence  of  melanomas  in  Grey  horses  is  significantly  correlated  to  the 
presence of a 4.6 kb non-coding duplication in STX17. Melanomas can also 
occur in horses of the colour cremello, characterized by pink skin, blue eyes 
and c r e a m e d  c o l o u r e d  o r  w h i t e  h a i r .  T h e s e  h o r s e s  h a v e  a  very  weak 
melanin production, but the ones with the duplication in STX17 still get 
melanoma (Paper III). This fact supports the theory that the mutation is 
responsible for the development of tumours. 
 
 
Genetics of melanoma 
Both environmental and genetic factors contribute to the risk of developing 
melanoma.  In  humans,  light  skin  colour,  the  inability  to  tan,  blue  eyes 
(Gilchrest  et  al.,  1999) a n d  the  presence  of    many  freckles  and  moles 
(Gandini et al., 2005) are correlated with an increased risk of melanoma   24 
development.  However,  many  individuals  fulfilling  the  physical  criteria 
never  develop  melanoma,  while  others  not  fulfilling  them  have  a  strong 
familial  record o f  m e l a n o m a .  T h i s  d e m o n s t r a t e s  t h a t  i n  c e r t a i n  t y p e s  o f  
melanoma, there is a genetic predisposition to the disease.  
The CDKN2A locus has been denoted “the familial melanoma locus”, 
due to its strong association to the familiar forms of the disease. Loss-of-
function mutations in CDKN2A have been shown to be a major risk factor 
for familial forms of melanoma in humans (Randerson-Moor et al., 2001, 
Goldstein et al., 2008). CDKN2A encodes two different proteins, INK4A 
and ARF, through the usage of alternative promoters and first exons. Both 
proteins  have  crucial  functions  in  cell  cycle  progression  by  indirectly 
regulating  two  tumour  suppressors:  the  retinoblastoma  protein  (RB)  and 
p53. INK4 inhibits cyclin-D-dependent kinases, causing cell cycle arrest in 
the G1 phase. The ARF-MDM2-p53 network both regulates the cell cycle 
and transition from G1 to S-phase and directs the cell to apoptosis (Quelle 
et al., 1995). When INK4A is lost, the cell cycle progression is consequently 
allowed to continue in an uncontrolled manner, and when ARF is lost, this 
results in the inactivation of the p53 pathway. 
Two  other  genes  of  major  importance  in  melanoma  are  NRAS a n d  
BRAF.  BRAF h a s  b e e n  shown  to  be  mutated  in  50-70%  of  human 
melanomas  while  NRAS i s  m u t a t e d  i n  b e t w e e n  1 5 -30%  (Davies  et  al., 
2002). The most common mutation in BRAF is the glutamic acid for valine 
substitution  at  position  600  (V600E),  and  in  NRAS t h e  r e p l a c e m e n t  o f  
leucine for glutamine at position 61 (Q61L) (Davies et al., 2002). Mutations 
in both BRAF and NRAS result in the activation of the ERK pathway, 
leading  to  increased  cell  proliferation  and  survival  (Eskandarpour  et  al., 
2005, Gray-Schopfer et al., 2005). BRAF is also mutated in up to 80% of 
benign  naevi  (Pollock  et  al.,  2003),  but  the  progression  of  naevi  to 
melanoma  is  a  rare  event  and  mutated  BRAF a l o n e  i s  n o t  s u f f i c i e n t  f o r  
initiating melanoma development (Gray-Schopfer et al., 2007).  
 
 
Gene expression and regulation 
Most cells within an organism have the same set of genes, yet the many cell 
types  look  very  different.  Melanocytes  are  small,  brown,  black,  or 
yellow/red and have long, graceful arms, while erythrocytes, the red blood 
cells, are big, bright red and round and lack a nucleus. The gene setup is not 
the only factor determining the appearance of the cells, but what makes the   25 
differences is which genes are expressed. Every cell type expresses a specific 
set of genes essential for its function and phenotype, and the expressed genes 
can also vary during different time points in the same cell type.  
 
 
Non-coding DNA and regulatory elements 
The  regulation  of  gene  expression  is  governed  at  many  levels  and  by 
different means. Thirty years ago, the non-coding part of the genome was 
believed to be “junk DNA” with no dedicated function, a term introduced 
in 1972 by Susumu Ohno (Ohno, 1972). In 1980, Leslie Orgel and Francis 
Crick wrote in a review in Nature that junk DNA has “little specificity and 
conveys little or no selective advantage to the organism” (Orgel and Crick, 
1980). Today, we know that much of the non-coding part of the genome is 
very  important,  since  non-coding  regulatory  elements  that  regulate  gene 
expression, both on the transcriptional and translational level, can be found 
there.  Some  non-coding  regions  could  be  of  minor  importance  for  the 
viability  of  organisms,  as  shown  by  Nobrega  et  al.  (2004)  through t h e  
deletion of megabases of non-coding DNA in mice, an experiment which 
did not rend any visible effects on the phenotype. 
The non-coding part of the genome contains promoters, enhancers and 
repressors  that  regulate  the  expression  of  genes  by  binding  specific 
transcription factors. The promoters are typically found directly upstream of 
a gene, while enhancers and repressor elements can be found both in the 
introns  and  in  the  near  vicinity  of  a  gene,  but  also  megabases  away. 
Transcription factors binding to regulatory DNA-elements and other factors 
interact with genes and the RNA polymerase machinery in order to regulate 
the  transcription  process.  From  this,  it  is  determined  how  much  gene 
product, protein, will be produced. 
 
 
Luciferase assays 
Why use glowing genes? 
Reporter  gene  assays  are  widely  used  in  cell  biology  to  study  gene 
expression or other cellular activities associated with gene expression. Two 
of  the  most  commonly  used  reporter  genes,  Green  Fluorescent P r o t e i n  
(GFP) (Shimomura et al., 1962, Chalfie et al., 1994, Heim et al., 1995) and 
firefly luciferase (de Wet et al., 1987), have been brought to laboratories   26 
from  nature, w h e r e  in  their  native  states  these  chemicals  make j e l l y f i s h  
(Aequorea  victoria)  and  fireflies  (Photinus  pyralis)  glow.  In  the  lab,  the 
expression of reporter genes in eukaryotic cells is highly optimized, making 
it possible to fuse the DNA segment of interest with the reporter gene and 
to c l o s e l y  f o l l o w  t h e  e f f e c t  o n  g e n e  e x p r e s s i o n  b y  m e a s u r i n g  t h e  
fluorescence or luminescence, respectively.  
The  luciferase  assay  is a  sensitive  and  easily  measured m e t h o d  f o r  
exploring differences in gene expression. Two kinds of luciferases are used 
in a typical dual luciferase assay: the firefly luciferase and sea pansy (Renilla 
reniformis) luciferase.  The substrate for Renilla luciferase is different from the 
substrate for firefly luciferase, and because of this, cross activation between 
the reactions catalyzed by the different luciferases cannot occur. The vector 
expressing  the  Renilla l u c i f e r a s e  h a s  c o n s e q u e n t l y  b e e n  e s t a b l i s h e d  as  a 
control vector cotransfected with the experimental firefly luciferase vector in 
order  to  normalize  for  differences  in  transfection  efficiency,  number  of 
transfected cells or sample handling.  
 
 
How to perform a luciferase assay 
Both the firefly and the Renilla luciferase gene can be found in a variety of 
commercially  available  vectors,  suitable  for  different  aspects  of  gene 
expression studies, i.e. for investigating the effect of promoters, enhancers or 
other regulatory elements. The DNA fragment to be studied, often 100-
2000 nucleotides long, is cloned in front of the luciferase gene into the 
vector, and if necessary combined with promoters or regulatory elements. 
When the vector is transfected into any kind of mammalian cells, a 61 kDa 
protein is translated from the luciferase gene, and the amount of this protein 
is regulated by the DNA fragment cloned in front of the gene. Between 24-
48  hours  after  the  transfection,  the  cell  walls  are  destroyed  so  that  the 
luciferase  protein  can  be c o l l e c t e d  i n  a  s o l u tion.  Luciferase  catalyses  the 
bioluminescent reaction where beetle luciferin is converted to oxyluciferin 
and light. As such, beetle luciferin needs to be added to the solution in 
order for light to be produced. The luminescence is used as a measurement 
of the amount of luciferase produced from the vector with the cloned DNA 
fragment.  
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Performing the optimal luciferase experiment 
Despite the relative simplicity of the assay, there are several points that need 
to  be  carefully  considered  and  optimized  when d e s i g n i n g  a  l u c i f e r a s e  
experiment. Care has to be taken with respect to insert length and fragment 
composition. Too long inserts (over 2000 nucleotides) often give results that 
are hard to interpret, since many different regulatory regions in the insert 
could have synergistic effects on the expression of luciferase.  
Another very important aspect in every experiment is to optimize the 
type of Renilla vector to be used. The Renilla luciferase gene can be found in 
combination with several different promoters, e.g. herpes simplex virus type 
1  thymidine  kinase  (HSV-1  TK)  promoter,  simian  virus-40  (SV-40) 
promoter  and  the  cytomegalovirus  (CMV)  promoter,  or  without  any 
promoter, but still with a low, basal expression from the gene. Different 
promoters have different activities in different cell types, and primarily a 
stable  and  sufficiently  high  expression  from  the  Renilla g e n e  m u s t  b e  
ensured. A common problem with promoter-based Renilla vectors is the 
possibility of transactivation of the promoter, either from factors common in 
the  cell  type  in  use,  or  from  your  experimental  vector  or  any  factor 
cotransfected  and  expressed  with  your  experimental  vector.  The 
transactivation  results  in  a  higher  Renilla l u c i f e r a s e  v a l u e  t h a n  w o u l d  
normally have been observed, and often the transactivation, if occurring, 
could be different between different experimental vectors in the same assay. 
Some factors can also have a suppressing effect on the promoters in the 
Renilla vectors. Several studies have pointed out the effects of transactivation 
of promoter based Renilla control vectors, for example in the case of factors 
as Nor-1 (NR4A3) (Matuszyk et al., 2002) and Ras (Behre et al., 1999). 
Often this problem can be circumvented by using the promoterless Renilla 
vectors, provided that the luciferase gene is expressed to a satisfactory level 
in the cell type used. 
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Present Investigations 
 
Identification and characterization of the mutation causing 
Greying with age and melanoma in horses (Paper I, III and IV) 
Background  
The Grey phenotype in horses has fascinated humans for several thousand 
years, judging from early historical records of the phenotype. Grey horses 
are mentioned in European, Asian and Native American mythology, and 
one of the oldest written records of the presence of white horses is by the 
Greek historian Herodotus, who describes the Persian emperor Xerxes (in 
reign from 485 to 465 BC) as keeping sacred white horses (Herodotus, 7.40) 
and another Persian emperor Cyrian being accompanied by white horses 
when he conquered Babylon (Herodotus, 1.189). Throughout history, the 
white horse has been commonly used to manifest purity, power and status 
for its owner or rider, and as a consequence of this, the phenotype has been 
favoured in breeding over hundreds of generations. Today, white horses are 
still very popular and exist in most breeds around the world, in particular 
within the Lipizzaner breed used in the Spanish riding school in Vienna, and 
also in Arabian horses. 
 Horses that become grey are born any colour, but they gradually loose 
the hair pigmentation and finally become white by the age of 6-8 years. The 
pigmentation loss only affects the hair, and the skin stays dark throughout 
life (Figure 5A). Melanomas are frequently occurring among Grey horses, 
usually in the later stages of life. It is generally claimed that 70-80% of Grey 
horses older than 15 years have melanomas (Sutton and Coleman, 1997, 
Fleury et al., 2000), and that the lesions start to develop early, by the age of 
5-6 years (Lerner and Cage, 1973). Many Grey horses also develop vitiligo-  30 
like skin depigmentation, commonly seen on the muzzle and under the tail 
(Lerner and Cage, 1973). A characteristic for many grey horses is spots of 
dark hair in the white fur. A horse with these spots is called “flea-bitten”, 
due to the illusionary pattern of dark flies on the horse (Figure 5B). Some 
Grey horses develop large patches of red pigmentation in so called “blood 
marks” (Figure 5C). 
 
Figure 5. Greying with age in horses. A. Partially paralyzed Grey horse diagnosed 
with  multiple  internal  melanomas.  The  shaved  areas  show  the  dark  skin 
pigmentation. B. Grey horse with characteristic speckling (small spots of pigmented 
hair, also called “flea-bitten” Grey). Photos by Monika H. Seltenhammer. C. Grey 
horse with red “blood marks”. Photo by Emilie Kajle. 
 
The Grey-causing mutation was assigned to horse chromosome 25 by three 
independent research groups in 2002 (Henner et al., 2002, Locke et al., 
2002,  Swinburne  et  al.,  2002) a n d  w a s  l a t e r  f i n e -mapped  to  a  region 
corresponding to 6.9 Mb on human chromosome 9q (Pielberg et al., 2005). 
In  paper  I,  we  used  more  than  800  horses  from  14  different  breeds  to 
narrow  down  the  region  with  the  mutation  to  352 k b  o n  h o r s e  
chromosome 25, and subsequently also to identify the causative mutation to 
be a 4.6 kb intronic duplication in the STX17 gene. This gene had not 
previously been linked to pigmentation. In paper III, we resequenced the 
entire  352  kb  Grey  haplotype,  and e x c l u d e d t h e  o c c u r r e n c e  o f  a n y  
additional mutations linked to the phenotype. In the same paper, we also 
showed a  d i f f e r e n c e  i n  c o p y  n u m b e r  o f  t h e  d u p l i c a t i o n  b e t w e e n  
constitutional and tumour DNA, with the highest copy number in tumours 
classified as aggressive. The functional properties of the Grey duplication 
were investigated in paper IV, where with luciferase assays, we identified a 
strong  melanocyte  specific  regulatory  element  in  the  duplication.  This 
region contains a binding site for the transcription factor MITF, important 
for the development of melanocytes from stem cells. In summary, papers I, 
III  and  IV  in  this  thesis  describe t h e  j o u r n e y  f r o m  f i n e -mapping  and 
identification, t o  f u n c t i o n a l  c h a r a c t e r i z a t i o n  o f  t h e  m u t a t i o n  c a u s i n g  h a i r  
greying and melanoma in the horse.    31 
Results and Discussion: Paper I 
Our initial hypothesis was that all Grey horses had inherited the mutated G 
(Grey)  allele  from  a  common  ancestor,  since  the  phenotype  has  been 
favoured  in  selective  breeding  for  hundreds  of g e n e r a t i o n s .  SNPs  (single 
nucleotide polymorphisms) in the previously assigned 6.9 Mb region were 
then identified and screened on a panel of Grey and non-Grey horses. The 
SNPs in the crucial 350 kb interval showed complete linkage disequilibrium 
with  the  Grey  phenotype  across  eight  breeds,  while  SNPs  flanking  the 
interval did not, implying that historical recombination events had occurred 
and that regions outside these flanking markers could be excluded. The 350 
kb Grey haplotype is surprisingly large, given that our material included 
populations as divergent as Icelandic and Arabian horses which have been 
separated for at least 1000 years. This implies a low rate of recombination in 
the region, which was also indicated in the previous linkage study (Pielberg 
et al., 2005). The conclusion from this was that the causal mutation was 
located  in  this  interval,  and  that  all  700  Grey  horses, t e s t e d  f r o m  e i g h t  
different  breeds, h a d  i n h e r i t e d  t h e  m u t a t i o n  f r o m  a  c o m m o n  a n c e s t o r. 
Interestingly, one non-Grey haplotype identical to the Grey haplotype for 
all  tested  SNPs,  but  not  containing  the  duplication,  was  found  in  one 
Arabian horse. It is possible that this haplotype represents the “ancestral” 
haplotype for Grey, the haplotype present in the horse population before 
the occurrence of the mutation. 
The  350  kb  Grey  haplotype  contained  four  genes:  NR4A3 ( n u c l e a r  
receptor subfamily 4, group A, member 3), STX17 (syntaxin 17), ERP44 
(endoplasmic  reticulum  protein  44,  formerly  known  as  TXNDC4: 
thioredoxin  domain–containing-4ƹ′)  and  INVS ( i n v e r s i n ) .  N o n e  o f  t h e s e  
genes had previously been indicated in any pigmentation disorder, making 
them interesting candidate genes for closer investigation. The four genes 
were first analyzed by Northern blot and quantitative PCR using liver and 
muscle tissue from one Grey and one non-Grey horse, and melanoma tissue 
from a heterozygous and a homozygous Grey horse. The results showed that 
all  four  genes  were  expressed  in  melanomas,  and  no  variant  transcripts 
unique to Grey horses were detected. However, the NR4A3 expression in 
Grey melanoma tissue was strikingly high, compared to Grey and non-Grey 
muscle and liver, and compared to the other three genes. Southern blot 
analysis of genomic DNA, using full coding regions as probes, revealed no 
polymorphisms for NR4A3, ERP44 or INVS, but a 4.6 kb insertion was 
present in STX17 in Grey horse samples. Long-range PCR revealed that the 
insertion was a duplication located in intron 6 of STX17. By sequencing the 
intron, the exact position of the duplication could be determined, and a   32 
diagnostic PCR-based test for the duplication was developed to screen more 
than  800  Grey  and  non-Grey  horses  from  14  different  breeds.  The 
duplication was detected in all Grey horses but in no non-Grey horses, and 
the statistical analysis of the genotype-phenotype correlation for close to 700 
Lipizzaner horses showed that horses homozygous  (G/G) for the mutation 
showed more rapid greying and were more homogenously white in the final 
stage of the process compared with Grey heterozygotes (G/g) (Figure 6). 
Homozygote  Grey  horses a l s o  h a d  s i g n i f i c a n t l y  h i g her i n c i d e n c e  o f  
melanoma  and  vitiligo  and  almost  no  speckling.  We  also  tested  if  Grey 
horses carrying the loss-of-function mutation in ASIP were more prone to 
melanoma, and the statistical analysis of horses older than six years showed a 
highly significant association between ASIP genotype and the incidence of 
melanomas. This finding implies that increased MC1R signaling promotes 
melanoma development in Grey horses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Analysis of phenotypic differences between heterozygous (G/g) (black 
lines)  and  homozygous  (G/G)  (red  lines)  Grey  Lipizzaner  horses.  A.  Degree  of 
lightness, measured as light reflectance. B, C and D. Grade of melanoma, vitiligo 
and speckling.  
 
Since the STX17 duplication is located in intron 6, just upstream of the 
initiation  of  a  short  alternative  transcript o f  t h e  g e n e ,  we  also  aimed  at 
studying the relative expression of the long and short transcripts of STX17 
in various tissues from Grey and non-Grey horses by quantitative PCR. The   33 
long and the short form showed very similar expression patterns, and both 
showed high expression in Grey melanomas compared with liver and skin 
from both Grey and non-Grey horses. To study the differential expression 
more closely, we quantified the relative expression of alleles in melanomas 
from  three  G/g h o r s es  using  SNPs  located  in  the  5'UTR  of  the  short 
transcript (this analysis was not possible for the long form due to the lack of 
suitable polymorphisms). cDNA sequences from all three melanoma samples 
revealed expression of only one allele, indicating differential expression of 
the short isoform. The same analysis was performed with NR4A3 cDNA 
from two G/g horses, and this revealed NR4A3 expression from only the 
Grey  haplotype,  indicating  that  a  cis-acting  regulatory  mutation  was 
underlying  the  upregulation  of  the  expression.  Genomic  DNA  from  the 
same  individuals w a s  u s e d  as  a  control t o  e n s u r e  t h a t  the  differential 
expression was not due to chromosome loss in the tumor.  
In this study, we also showed that the 4.6 kb intronic duplication that 
causes greying with age in horses, only results in pigmentation loss in the 
hair, while the skin stays dark throughout life. Actually, the dermis of these 
horses,  which  go  on  to  develop  melanoma,  instead  accumulates 
melanocytes. Here, the exact mechanism by which the pigment loss and 
melanoma development occurs is not known, but the significant correlation 
of  both  phenotypes  with  the  mutation  shows  that  the  hair  and  skin 
melanocytes in Grey horses are regulated independently. 
 
 
Results and Discussion: Paper III 
Here, we wanted to investigate whether the duplication in STX17 showed 
copy number variation among Grey horses, since duplications are known to 
be  genetically u n s t a b l e ,  and  we  also  wanted  to  exclude  that  other 
polymorphisms  than  the  duplication  were a s s o c i a t e d  w i t h  Grey b y  using 
massively parallel resequencing of the Grey haplotype.  
  In  order  to  investigate  the  possible  copy  number  variation,  we  used  a 
TaqMan Copy Number Assay approach where we designed test probes to 
quantify sequences inside and outside the duplicated region, and also over 
the 5'end of the duplicated sequence. First, 94 homo- and heterozygous 
Grey Lipizzaner horses were tested for the copy number of the duplicated 
sequence. Secondly, we analyzed DNA both from tumours and from several 
equine  melanoma  cell  lines,  When screening copy number expansion in 
constitutional DNA (Figure 7A), we found only one horse out of about 90 
with an estimated copy number of 5 or higher, whereas the corresponding   34 
figure  for  tumour  DNA  was  5  out  of  8 ( samples  marked  by  asterisk  in 
Figure 7B) (P = 5x10
-6; Fisher’s exact test). In tumour DNA from one Grey 
horse  and  from  two  horse  melanoma  cell  lines,  the  copy  numbers w ere 
estimated to 3, as expected from their Grey genotypes. The elevated copy 
number in tumour DNA compared with constitutional DNA demonstrates 
the first set of proof for the duplication in STX17 being a driving force in 
melanoma development in Grey horses. 
 
Figure 7. Copy number variation of the STX17 duplication. (A) Copy number 
assay for the STX17 duplication in constitutional DNA from 94 Grey Lipizzaner 
horses and one calibrator sample with known copy number of 2. (B) Copy number 
assay for the STX17 duplication in constitutional DNA and/or melanoma DNA 
using three different probes. c = constitutional DNA, mel = melanoma DNA. The 
sample denoted ‘Calibr’ is a g/g individual with a known copy number of 2, used as 
a calibrator in the analysis. Constitutional DNA from one G/g and one G/G horse 
was tested in the assay and the results are shown as a reference for the copy number 
expected from each genotype. Brackets surround the equine melanoma cell lines or 
the  paired  constitutional  and  melanoma  DNA  samples.  Error  bars  represent  the 
copy number range from the CopyCaller™ Software analysis of quadruplicates in 
each assay. 
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The experimental design for the resequencing of the Grey haplotype was to 
use one horse homozygous for Grey, and the horse with the closely related 
haplotype identified in paper I, a haplotype identical to Grey for all tested 
polymorphisms  except  for  the  duplication.  This  experimental  design  was 
chosen  to  minimize  the  number  of  sequence  polymorphisms  uniquely 
associated with Grey in the sequence analysis. Five other non-Grey horses 
were also included in the experiment.  
The  analysis  of  the  resequencing d a t a  identified  15  SNPs  uniquely 
associated  with  the  Grey  homozygote,  and  these  SNPs  were  further 
investigated by Sanger sequencing in three additional horses; Twilight, the 
heterozygous Grey horse used to generate the genome reference sequence, a 
second homozygous Grey Lipizzaner horse and the non-Grey horse carrying 
the  closely  related  haplotype.  This  analysis  excluded  all  but  seven l o c i  
(SNP1-7),  which w e r e  s e l e c t e d  f o r  f u r t h e r  a n a l y s i s  b y  T aqMan  SNP 
Genotyping  Assays  in  357 h o m ozygous,  heterozygous  and  non-Grey 
individuals,  in  order  to  investigate  a  possible  association  to  the  Grey 
phenotype. The results showed that none of the investigated polymorphisms 
showed a perfect concordance with the Grey phenotype, as the duplication 
does.  
However,  the  analysis  of  the  seven S N P s  r e v e a l e d  o t h e r  i n t e r e s t i n g  
results; the non-reference allele at the SNP1 and SNP3 loci was only found 
in  Grey  individuals,  which  means  that  these  SNPs  must  have  occurred 
subsequent  to  the  Grey m u t a t i o n .  For  SNP1,  a  fourth,  distinct  separate 
genotype cluster was detected in the TaqMan analysis (where ideally only 
three clusters, one for each genotype, should be observed). By sequencing 
the amplicon for the individuals in this cluster, a SNP in the TaqMan probe 
site was detected, resulting in a lower G-allele signal in the assay, thereby 
creating a fourth cluster. Since the G nucleotide is associated with Grey, this 
analysis revealed a third confirmed SNP that must have occurred on the 
Grey haplotype subsequent to the Grey mutation event. 
SNP4  and  SNP6  showed  a  nearly  perfect  association  with  the  Grey 
genotype, but with the exception for two non-Grey and four heterozygous 
Grey  individuals.  These  two  SNP  are  located  just  outside  the  haplotype 
block showing complete LD with the Grey mutation. In conclusion, we 
failed to identify any other sequence polymorphism uniquely associated with 
Grey,  where  the  genotype  distribution  perfectly  matched t h e  p h e n o t y p e  
distribution at the Grey locus.   36 
Results and Discussion: Paper IV 
In this study, we aimed at functionally dissecting the duplicated region in 
Grey horses in order to reveal the mechanisms behind the cis-regulatory 
activity.  We  investigated p o t e n t i a l ly r e g u l a t o r y  r e g i o n s   in  the  duplicated 
sequence by testing their regulatory activity in luciferase assays, and further 
characterized one of these regions.  
We first identified the human region corresponding to the STX17 4.6 kb 
duplicated region by a BLAT search against the human genome sequence in 
the  UCSC  Genome  Browser  (http://genome.ucsc.edu/).  From  the  track 
regPotential7X,  only  available  in  the  Human  Mar.  2006  assembly 
(NCBI36/hg18),  seven  well-defined  potential  regulatory  regions  were 
identified.  All seven regions were found in the horse genome, and all were 
tested for their regulatory activity in both murine melanocytes and murine 
myoblasts.  The  results  from  the  luciferase  assay  revealed  that  one  of  the 
elements, Reg3, had a strong melanocyte specific regulatory activity (Figure 
8).  When  the  element  was  duplicated  in  order t o  mimic t h e  g e n e t i c  
landscape in Grey horse STX17, the activity increased by 2-fold. 
Bioinformatic analyses of the equine sequence for Reg3 revealed one 
near-consensus NGFI-B-response element (NBRE), to which NR4A3 has 
been shown to bind (Paulsen et al., 1995), and two potential MITF binding 
sites  separated  by  83  bp,  both  containing  the  perfect  core  nucleotides 
CATGTG. W h e n  d e l e t i n g  t h e  N B R E  f r o m  t h e  o n e -copy  Reg3,  the 
activity  was  dramatically  elevated,  from  8-fold  to  more  than  20-fold. 
Deleting the MITF binding sites resulted in a reduced activation, for MITF 
site 1 from 8- to 2-fold, equal to the activity in the myoblasts, and for MITF 
site 2 the reduction in activity was from 8 to 5-fold. MITF has been shown 
to be crucial for melanocyte development and survival (Opdecamp et al., 
1997), and is a very interesting candidate for the regulation of the Reg3 
activity in melanocytes.   37 
Figure 8. Luciferase activity of regulatory regions in the STX17 duplication. Firefly 
luciferase reporter levels in relation to control Renilla luciferase levels. Error bars 
represent standard deviations of triplicates in one experiment. The results shown are 
representative  for  three  repeated  independent  experiments.  Results  for  the 
constructs containing regulatory regions 1-7 (Reg1-7), element 3 in two copies 
(Reg3dup)  and  regulatory  element  3  with  deleted  NBRE,  MITF1  or  MITF2 
binding  sites  (DelNBRE,  DelMITF1,  DelMITF2)  are  shown.  In  addition,  the 
results from one construct containing the STX17 promoter region (Pr. STX17) and 
the  empty  vector  pGL3-Basic  (Empty  vector)  are  shown  as  references. 
RLU=Relative Luciferase Units. 
 
Deletion of MITF site 1 showed a more dramatic effect on the reduction of 
the  activation  than  deletion  of  MITF  site  2.  Both  sites  could  be  of 
importance for the melanocyte-specific activity, since the deletion of each of 
resulted in significantly lower activity.  
Deletion  of  the  near-consensus  NBRE  sequence  in  the  melanocyte-
specific r e g u l a t o r y  e l e m e n t  r e s u l t e d  i n  a  m e l a n o c y t e -specific  increase  of 
activation compared to empty vector activity; from 8-fold, when present, to 
more than 20-fold when deleted. This indicates that this sequence binds a 
transcriptional repressor present in melan-a cells, but it is unlikely that this 
repressor  protein  is  NR4A3 s i nce NR4A3 s how onl y l ow expr es s i on i n 
melan-a  cells a n d  N R 4 A 3  h a s  n o t  p r e v i o u s l y  b e e n  s h o w n  t o  a c t  a s  a  
transcriptional repressor.  
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Future prospects 
In paper I, III and IV of this thesis, the progress from mapping of the Grey 
mutation in horses, to the functional dissection of its mechanisms of action, 
is  presented.  Even  if  many  of  our  initial  questions  have  been  answered, 
several  question  marks  still  remain.  The  mechanism  by  which  the 
duplication in STX17 causes hair greying and melanoma has not entirely 
been explained, but we have approached the goal from numerous angles.  
To further elucidate the mechanism, and in order to see if other genes in 
addition to STX17 and NR4A3 have an altered expression, a transcriptome 
analysis  between  non-Grey  and  Grey  melanocytes  could  be  performed. 
Also, it would be very interesting to compare the gene expression profiles 
between hair follicles from the dark speckles and the white fur, and also the 
“blood marks” and the white fur in the same individuals. 
The regulatory element 3 (Reg3) from paper IV, which shows a strong 
melanocyte  specific  activity,  is  currently  being  investigated  in  zebrafish 
enhancer assays in order to examine the extent to which the element shows 
expression in neural crest cells during development. A high expression in 
neural crest cells could indicate that this element affects the development 
and/or  migration  of  melanocytes  at  an  early  stage.  The  effect  of  MITF 
binding to this element further supports a possible role during melanocyte 
development or migration. Also, it is possible that NR4A3 can promote 
transcriptional activation mediated by this regulatory region by interfering 
with the binding of a repressor protein to the NBRE site, but this needs to 
be investigated more in detail, for instance by overexpressing NR4A3 in 
melan-a cells. 
The results from the research presented in paper I, III and IV could also 
eventually have practical repercussions for the diagnosis and treatment of 
Grey horse melanoma. Today it is possible to genotype horses for the Grey 
mutation,  but  the  existing  long-range  PCR  assay  could  be  replaced  by 
another  genotyping  method  in  order  to  perform  less  labour  intensive 
routine genotyping. There is a high demand from breeders and owners for 
genotyping  Grey  horses  in  order  to  predict  both  the  genotype  and 
phenotype of the foal. According to the results from paper III, there is copy 
number variation of the duplication in melanoma tissue, and to some extent 
there  appears  to  be  higher  copy  numbers i n  t u m o u r s  w i t h  a  f a s t e r  
progression. Testing the copy number in tumours could be a valuable tool 
as an indication of the malignancy of the tumour, and the copy number of 
the duplication could also be used as a guide for surgical removal of putative 
malignant tumours.   39 
Sex-linked barring in the domestic chicken (Paper II) 
Background  
The  Sex-linked  barring  pattern  in  chickens  is  characterized  by  the 
pronounced  black  and  white  stripes  on  the  feathers  (Figure  9A  and  B). 
Similar barring patterns are found among many other bird species, like the 
peregrine falcon (Figure 9D) and zebra finch. The reason for the presence of 
these patterns in nature could be due to their good camouflaging properties. 
In chickens, a less pronounced barring pattern also exists, called autosomal 
barring. Sex-linked barring is characterized by bars with a complete absence 
of pigmentation, but in autosomal barring the bars vary between darker and 
lighter pigmentation, which results in a more irregular pattern. 
 
Figure 9. A. An adult rooster (B*B⁄B*B) showing the Sex-linked barring feather 
pattern. B. A tail feather taken at 8 weeks of age from a B*B homozygous male 
(top) showing considerably wider white bands compared to a feather taken from a 
B*B⁄W hemizygous female (bottom). C. At hatch, Barred Plymouth Rock chicks 
display a white spot on their heads. The B*B⁄W female (left) has a smaller spot 
compared  to  the  B*B⁄B*B m a l e  ( r i g h t ) .  D .  Peregrine  falcon  exhibiting  barred 
feathers. Photos A, B and C supplied by Christa F. Honaker and photo D by Jorma 
Luhta/naturepl.com. 
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The molecular mechanisms causing Sex-linked barring were first explored 
in the late 1920’s and 1930’s. The first theory was published in 1929 and 
relied  on  skin  transplantation  experiments.  The  authors  performed  skin 
transplants between one-day old barred and non-barred chickens, and saw 
that  skin  transplanted  from  one  sex  to  the  other  grew  feathers  that  in 
structure were like those of the host and, in colour and barring pattern, like 
those of the donor. From this they suggested that the Sex-linked barring 
pattern  could  be  caused  by  a  rhythmic  variability  in  metabolism  or 
hormonal secretions, and that a specific physiological “Sex-linked barring 
factor”  must  be  present  in  the  skin,  since  the  skin  was  the  determining 
factor for which pattern the feathers developed (Danforth, 1929). A few 
years  later i n  1 9 3 4 ,  M o n t a l e n t i  m a d e  t h e  o b s e r v a t i o n  t h a t  t w o  a d j a c e n t  
barring  feathers  did  not  necessarily  develop  the  white  and  black  bands 
simultaneously (Montalenti, 1934). Today, the conclusion that can be drawn 
from these two early examinations, is that a gene product causing barring 
must  act  in  the  feather  follicle,  since  Danforth  noticed  that  the  barring 
pattern followed the transplanted skin (feather follicles), and Montalenti saw 
differences between different feathers in the same individual.  
A  decade  later, i n  1 9 4 4 , N i c k e r s o n  w as  the  pioneer  of  the  theory 
claiming premature melanocyte death in the feather follicles of Sex-linked 
barred chickens, causing the white band development (Nickerson, 1944). 
This theory was confirmed 40 years later by Bowers and Asano (Bowers, 
1984), and both Nickerson and Bowers suggested that the premature cell-
death was the cause of the white band formation. Bowers continued his 
work on this theory, and published two sequential papers where he first 
proposed that the white bands formed due to an autophagic degeneration of 
the  melanocytes  at  the  edge  of  the  black  bands  in  the  feather  follicle 
(Bowers, 1988), and later his group suggested that the melanocytes in Sex-
linked barred chickens would be more sensitive to oxidative stress than the 
melanocytes in the wild-type chickens. In the later work, the hypothesis was 
that the melanocytes would die due to high levels of reactive oxygen species 
(ROS)  present  during  pigment  production,  and  when  the  ROS  levels 
would  decrease,  pigmentation  could  progress  normally  and  produce  the 
black bars until the next increase in ROS levels (Bowers et al., 1994). 
The first mapping attempt of the Sex-linked barring locus was made by 
Bitgood  in  1988,  and  placed  the  locus o n  t h e  q  a r m  o f  the  male  sex 
chromosome Z (Bitgood, 1988). In 2009, Dorshorst and Ashwell narrowed 
the  locus  to  a  355  kb-region  on  the  distal  q  arm  of  this  chromosome 
(Dorshorst and Ashwell, 2009). In paper II, Sex-linked barring is mapped to 
the CDKN2A/B locus on chromosome Z, and the candidate mutations for   41 
Sex-linked  barring  are  presented  and  evaluated  for  their  functional 
properties. 
 
 
Results and Discussion 
By using linkage analysis and a set of 675 F2 chickens, we could assign the 
Sex-linked  barring l o c u s  t o  a  s e c t i o n  o n  c h r o m o s o m e  Z  c o n t a i n i n g  n i n e  
different genes. One of these genes stood out as an exceptional candidate; 
the  CDKN2A/B l o c u s .   Loss-of-function  mutations  in  this  gene  have 
previously  been  associated  with  familiar  forms  of  melanomas  in  humans, 
indicating an important functional role in melanocyte biology (Hussussian et 
al., 1994, Dracopoli and Fountain, 1996, Monnerat et al., 2007). As a result 
of  this,  a  new  marker  in  CDKN2A/B w a s  d e v e l o p e d ,  a n d  following 
screening in the F2 individuals no recombination could be detected between 
this marker and Sex-linked barring. With the hypothesis that all individuals 
carrying Sex-linked barring would share the same mutation, a 12 kb identical 
by descent (IBD) region in the CDKN2A/B locus was defined following 
the s e q u e n c i n g  of  a  number  of  individuals.  As  an  IBD  region,  this  is 
surprisingly small when compared for example to the 352 kb IBD region 
associated with Greying with age in horses (Rosengren Pielberg et al., 2008). 
This could be explained by the position of the region on the end of the Z 
chromosome q arm, a region that has been shown to have a high rate of 
recombination (Groenen et al., 2009).  
Of the 320 SNPs found in the Sex-linked barring IBD region, two non-
coding ones, one in the promoter region of the CDKN2A/ARF transcript 
(SNP1) a n d  t h e  n e x t  i n  t h e  f i r s t  i n t r o n  o f  t h e  s a m e  t r a n s c r i p t  ( S N P 2 ) , 
showed  nearly  complete  association  with  the  phenotype.  The  mutations 
were genotyped in 285 individuals divided over 51 populations, and showed 
a very strong association across populations. In addition to the two non-
coding SNPs, two missense mutations were identified at highly conserved 
sites in the ARF protein, V9D and R10C, and every bird tested with a 
confirmed  Sex-linked  barring  phenotype  carried  one  of  these  missense 
mutations. These mutations are found in a part of the ARF protein where 
mutations have been shown to be highly critical for the function of the 
protein (Kim et al., 2003, Moulin et al., 2008, di Tommaso et al., 2009). 
Functional  analysis  did  not  conclude  any  proofs  for  the  molecular 
mechanisms causing the barred feather pattern, but it did however clarify 
some  important  aspects  of  the  two  mutations,  SNP1  and  SNP2. 
Transcription factor binding site analysis showed that SNP1 was located in a   42 
putative E2F1 binding site, with the B*B-allele matching slightly better than 
the  B*N-allele.  This  finding  was  interesting  because  E2F1 i s  k nown  to 
regulate CDKN2A expression in both mouse (Lomazzi et al., 2002) and 
chicken cell lines (Kim et al., 2006). SNP2 was found to be located in a 
NFκB binding site, with a better match for the B*N sequence than the B*B 
sequence. The putative binding sites were investigated for the binding of 
each transcription factor by Electrophoretic Mobility Shift Assays (EMSA). 
No D N A -protein  complex  was  detected  with  the  oligonucleotides 
corresponding to the two SNP1 alleles, but a specific complex was obtained 
when oligonucleotides for both alleles at the SNP2 site were used, however 
no obvious difference was seen between the alleles. 
Luciferase reporter assays were also performed for SNP1 and SNP2 to 
test whether alleles at these loci influenced transcriptional activation, but 
there was no significant difference between alleles either for SNP1 or SNP2. 
The luciferase assay with cotransfection of the E2F1 transcription factor with 
the  constructs  harbouring  the CDKN2A (ARF)  promoter  confirmed  the 
results of Kim et al. (2006); that transcription of chicken CDKN2A, like 
mammalian CDKN2A, is activated by E2F1. However, we were unable to 
detect a significant difference in activity between the SNP1 alleles. When 
constructs containing all four combinations of SNP1 and SNP2 alleles were 
tested for possible interactions between SNPs, no significant differences in 
luciferase activity were detected. 
 
 
Future prospects 
The functional investigations of the candidate mutations turned out to be a 
difficult and not very straightforward task. The ARF proteins with the Sex-
linked barring wild type allele and each of the two missense mutations have 
been studied in preliminary luciferase assays with the aim to investigate their 
possible interaction or absence of interaction with the p53 promoter. This 
was because the main function of ARF (p14
ARF in humans, p19
ARF in mice) 
is  to  activate  p53  by  inhibiting  MDM2  (Figure  10),  which  results  in 
induction of the expression of numerous apoptosis and cell cycle inhibitory 
genes (Lowe and Sherr, 2003). Preliminary results indicate a close to 2-fold 
lower activation of the p53 promoter in the two constructs expressing the 
proteins with V9D and R10C missense mutations, compared to the wild 
type protein, which showed the same fold activation of the p53 promoter as 
the p14
ARF wild type form in humans (di Tommaso et al., 2009).    43 
This is the first study showing that mutations in the CDKN2A/B locus can 
cause variation in coat or plumage colour. It would therefore be interesting 
to study the possible role for this locus in determining colour diversity both 
among  birds  and  other  species.  Since  CDKN2A/B i s  l o c a t e d  o n  t h e  Z  
chromosome in birds and does not show dosage compensation, this locus 
may contribute to sexual dimorphism in avian plumage colour. For instance, 
the  zebra  finch  has  zebra  striped  feathers,  only  present  in  males,  and 
CDKN2A/B is an obvious candidate locus for this. According to the zebra 
finch genome assembly, CDKN2A/B encodes an ARF protein that just like 
the B2 allele differs from other vertebrate ARF proteins by not having an 
arginine  residue  at  position  10. T h i s  raises  many  questions  about  the 
molecular processes behind fascinating coat and plumage colours found in 
nature, questions that urge to be further investigated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  10.  The  ARF-MDM2-p53  network.  Elevated  expression  of  ARF,  as  a 
consequence of oncogenic signals or release of E2Fs, E2F1 in particular, results in 
the stabilization of p53 and upregulation of p53 target genes. ARF has been shown 
to regulate E2F1 expression (Parisi et al., 2002). The ARF protein binds to MDM2 
and inhibit its ubiquitin ligase activity. MDM2 modulates p53 activity by blocking 
its  transcriptional  activation  functions  and  by  promoting  its  ubiquitilation  and 
proteasome-mediated  degradation.  MDM2  is  transcriptionally  activated  by  p53, 
resulting  in  a  feedback  loop. p 5 3  c a n  c a u s e  t r a n s c r i p t i o n a l  r e p r e s s i o n  o f  A R F ,  
creating a feedback loop which modulates p53 activity. ARF induction can induce 
apoptosis,  but  the  usual  outcome  is  cell-cycle  arrest  in  the  G1  and  G2  phases. 
Illustration by Elisabeth Sundström, partly modified from Gil and Peters (2006).   44 
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Populärvetenskaplig sammanfattning 
Genetiska studier av husdjur bidrar till förståelsen av pigmentering 
och melanom 
Ända sedan människan tämjde sina första husdjur för tiotusentals år sedan, 
har vi genom avel skapat just de djur som vi har haft användning, nytta och 
nöje  av.  Detta  har  lett  till  en  fantastisk  mångfald a v  kroppsstorlekar, 
pälsfärger och kroppsformer bland våra husdjur, något vi idag med genetiska 
metoder kan studera på molekylnivå, och avgöra exakt vilka gener som ger 
upphov till vilka drag. I den här avhandlingen har vi genom att studera de 
genetiska  egenheterna  hos  två  framavlade  utseenden  i  våra  husdjur; 
avblekbar skimmel hos hästar och svart-vit randiga fjädrar hos höns, kunnat 
dra  slutsatser  om  molekylära  processer  och  signalvägar  som  leder  till 
förändringar  i  pigmenteringen  och  uppkomst  av  pigmenttumörer,  s.k. 
melanom.  På  denna  mest  grundläggande  cellnivå  är  processerna  ofta 
identiska mellan djur och människor, vilket gör att man genom den här 
forskningen också kan dra slutsatser om vad som händer i människor som 
har förändrad pigmentering eller får hudtumörer.  
Avblekbara skimlar föds normalt färgade, till exempel bruna eller svarta. 
Med åldern försvinner pigmenteringen gradvis i håret, och vid 6-8 års ålder 
är de flesta hästar mer eller mindre vita. Förloppet kan liknas vid hur många 
av oss människor förr eller senare får grått hår, och precis som hos oss är det 
bara håret som förlorar sin pigmentering hos hästarna, hudens färg förblir 
oförändrad,  vilket  hos  hästarna  innebär  svart.  Till  skillnad  från  gråhåriga 
människor, drabbas de avblekbara skimlarna i 8 fall av 10 av melanom, om 
de  lever  tillräckligt  länge.  Melanom  är  pigmentceller  som  förökar  sig 
ohejdat,  och  dessa  tumörer  kan  växa  sig  stora  som  en  knuten  hand h o s  
skimlar.  Oftast  hittar  man  dem  i  hud  som  saknar  behåring,  t.ex.  under 
svansen, vid munnen eller ögonen. I den här avhandlingen presenteras det 
arbete som startade med kartläggningen av den genetiska förändring som   46 
orsakar  förlusten  av  hårpigment  och  melanom,  och  som  fortsatte  med 
studier av hur förändringen påverkar pigmentcellerna. Vi kunde visa att alla 
vita hästar bär på samma förändring, och att den innehåller en region som 
har en starkt aktiverande effekt på andra gener, men bara i pigmentceller. Vi 
kunde  också  visa  att  förändringen  finns  i  fler  kopior  i  DNA  från 
tumörvävnad jämfört med DNA från blod eller hår, och i flest kopior i 
tumörer som är aggressiva. Detta visar att den genetiska förändring vi hittade 
påverkar tumörutvecklingen. 
Den  svart-vit-randiga  fjäderdräkten,  som  generellt  kallas  vattring  hos 
fåglar,  nedärvs  hos  höns  på  den  könskromosom  (Z)  som  finns  i  dubbel 
upplaga hos tuppar. Detta innebär att tuppar kan ha betydligt bredare vita 
ränder  på  fjädrarna  än  hönor.  Vi  ville  veta  var  den  eller  de  genetiska 
förändringar som orsakar mönstret fanns, för att kunna ta reda på närmare 
vad  som  händer  i  cellerna  när  fjädrarna  utvecklar  de  svarta  och  ljusare 
banden. I den här avhandlingen presenteras det arbete som ledde fram till att 
vi exakt kunde peka ut var dessa genetiska förändringar fanns. De låg i en 
gen  som  tidigare  har  visat  sig  vara  av  stor  betydelse  för  om  människor 
utvecklar en ärftlig form av melanom. Genen har också visats vara viktig för 
hur pigmentering styrs. 
Genom  att  i  genetisk  detalj s t u d e r a  t v å  u t s e e n d e n  m e d  a n n o r l u n d a  
pigmenteringsprocesser hos djur, har vi genom vår forskning kunnat bidra 
med  nya  ledtrådar  kring  de  mekanismer  som  styr  pigmentering  och 
uppkomsten av melanom, både hos djur och människor.   47 
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